Leishmaniasis: new approaches to disease control

被引：187

作者：

Davies, CR

Kaye, P

Croft, SL

Sundar, S

机构：

[1] Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England

[2] Univ London London Sch Hyg & Trop Med, Dis Control & Vector Biol Unit, London WC1E 7HT, England

[3] Banaras Hindu Univ, Inst Med Sci, Dept Med, Varanasi 221005, Uttar Pradesh, India

来源：

BRITISH MEDICAL JOURNAL | 2003年 / 326卷 / 7385期

关键词：

D O I：

10.1136/bmj.326.7385.377

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Leishmaniasis is one of the major infectious diseases affecting the poorest regions of the world, but new developments in diagnosis, treatment, and control offer some fresh hope.

引用

页码：377 / 382

页数：8

共 58 条

[41] PLACEBO-CONTROLLED CLINICAL-TRIAL OF SODIUM STIBOGLUCONATE (PENTOSTAM) VERSUS KETOCONAZOLE FOR TREATING CUTANEOUS LEISHMANIASIS IN GUATEMALA [J].

NAVIN, TR ;

ARANA, BA ;

ARANA, FE ;

BERMAN, JD ;

CHAJON, JF .

JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (03) :528-534

[42] Leishmaniasis vaccination: Targeting the source of infection [J].

Reed, SG .

JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (03) :F7-F9

[43] Rapid detection of Leishmania infantum infection in dogs:: Comparative study using an immunochromatographic dipstick test, enzyme-linked immunosorbent assay, and PCR [J].

Reithinger, R ;

Quinnell, RJ ;

Alexander, B ;

Davies, CR .

JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (07) :2352-2356

[44]

Reithinger R, 2001, EMERG INFECT DIS, V7, P872

[45] A randomized controlled trial of insecticide-treated bednets and chaddars or top sheets, and residual spraying of interior rooms for the prevention of cutaneous leishmaniasis in Kabul, Afghanistan [J].

Reyburn, H ;

Ashford, R ;

Mohsen, M ;

Hewitt, S ;

Rowland, M .

TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2000, 94 (04) :361-366

[46] Vaccination with heat-killed Leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against Leishmania major infection [J].

Rhee, EG ;

Mendez, S ;

Shah, JA ;

Wu, CY ;

Kirman, JR ;

Turon, TN ;

Davey, DF ;

Davis, H ;

Klinman, DM ;

Coler, RN ;

Sacks, DL ;

Seder, RA .

JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (12) :1565-1573

[47] Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran [J].

Sharifi, I ;

FeKri, AR ;

Aflatonian, MR ;

Khamesipour, A ;

Nadim, A ;

Mousavi, MRA ;

Momeni, AZ ;

Dowlati, Y ;

Godal, T ;

Zicker, F ;

Smith, PG ;

Modabber, F .

LANCET, 1998, 351 (9115) :1540-1543

[48]

Soto J, 2001, Clin Infect Dis, V33, pE57, DOI 10.1086/322689

[49] Treatment of cutaneous leishmaniasis with a topical antileishmanial drug (WR279396): Phase 2 pilot study [J].

Soto, JM ;

Toledo, JT ;

Gutierrez, P ;

Arboleda, M ;

Nicholls, RS ;

Padilla, JR ;

Berman, JD ;

English, CK ;

Grogl, M .

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2002, 66 (02) :147-151

[50] Rapid accurate field diagnosis of Indian visceral leishmaniasis [J].

Sundar, S ;

Reed, SG ;

Singh, VP ;

Kumar, PCK ;

Murray, HW .

LANCET, 1998, 351 (9102) :563-565

← 1 2 3 4 5 6 →